Will Viagra for women be released in 2015?

If clinical trials produce safe and effective results, a new drug, to revive the desire for "love" for women, is expected to be officially launched by the end of next year.

>>>Viagra helps women reduce pain on "red light"

In the face of the fact that 4 out of 10 women say they have been "cooled off" at some point in their lives and Viagra, the "first-aid drug" for men, is bringing profits of nearly $ 2.5 billion a year, pharmaceutical companies around the world are constantly trying to create a weak version of Viagra.

However, because the sexual desire of women depends very much on psychological factors, so the pharmaceutical companies are very struggling to find the right product to help the desire to "love" of women. Mike Wyllie, one of the people who invented Viagra, believes that the latest drug is developed by UK drug company ORLIBID, which can succeed while other competitors fail.

Active ingredient ORL101, a synthetic version of the hormone melatonin, is thought to work as Viagra for women.(Photo: Corbis)

ORLIBID medicines are designed to affect the brain, igniting the desire to "love" in the weaker sex. It is actually a synthetic version of melatonin, a hormone that is often associated with tanning, but also affects sexuality and appetite.

Pharmacists have long known the effects of melatonin on sexual desire, but have not found a way to encapsulate it in tablets, instead of injections. The pill form will be more convenient and less likely to cause side effects.

Melatonin tablets can cause nausea, but in return, they are not addictive. The inventors insist, just take 1 pill before taking 15 minutes of "sex " , the enhancement effect of "love" in the sisters will last for more than 2 hours.

The manufacturer hopes that, with the right dose, the active ingredient called ORL101 will restore the declining desire to "love" women, without making them use too much medicine. In addition, because ORL101 also affects appetite, this drug called 'Viagra pink' also has the potential to help weight loss.

ORLIBID has planned to conduct 3 studies on ORL101 for women. If the results prove it is safe and effective, the drug can be officially marketed by the end of 2015.